ALMS
Alumis Inc.

416
Loading...
Loading...
Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
168

Frequently Asked Questions

What is Market Cap of Alumis Inc.?
What is the 52-week high for Alumis Inc.?
What is the 52-week low for Alumis Inc.?
What is Alumis Inc. stock price today?
What was Alumis Inc. stock price yesterday?
What is the PE ratio of Alumis Inc.?
What is the Price-to-Book ratio of Alumis Inc.?
What is the 50-day moving average of Alumis Inc.?
How many employess does Alumis Inc. has?

Latest ALMS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.